Status:
COMPLETED
A Study of JUVÉDERM VOLUX® Injectable Gel for Chin Enhancement in Chinese Adults Using Real-World Evidence
Lead Sponsor:
Allergan
Conditions:
Chin Retrusion
Eligibility:
All Genders
18+ years
Brief Summary
This study will collect effectiveness and safety data on JUVÉDERM VOLUX® Injectable Gel for Chin Enhancement in Chinese Adults based on real world data.
Detailed Description
There will be 30 participants selected who undergo 3D imaging before and after JUVÉDERM VOLUX® treatment for digital analysis assessments. Up to 90 participants enrolled either prospectively prior to ...
Eligibility Criteria
Inclusion
- Participant has chin retrusion seeking chin enhancement who have received or plan to receive VOLUX chin treatment in Hainan Boao Super Hospital.
Exclusion
- History of hypersensitivity to lidocaine,HA, or Streptococcal protein
- History of tendency to develop hypertrophic scarring
- Untreated epilepsy or porphyria
- Current cutaneous inflammatory or infectious processes (eg, acne, herpes) in the treatment area
- Prior chin or jaw surgery, including cartilage grafts or implantation of any biomaterials
- Permanent filler, semi-permanent filler, or fat injected in the treatment area
- Temporary filler, other than VOLUX, injected in the treatment area within 12 months before enrollment
- Females who self-report current pregnancy or breastfeeding
Key Trial Info
Start Date :
February 4 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 28 2022
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04687046
Start Date
February 4 2021
End Date
February 28 2022
Last Update
February 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hainan Boao Super Hospital /ID# 235968
Qionghai, Hainan, China, 571434